<DOC>
	<DOCNO>NCT02708056</DOCNO>
	<brief_summary>The objective study evaluate efficacy safety sugammadex reverse profound neuromuscular block induce rocuronium infant patient</brief_summary>
	<brief_title>Sugammadex Given Reversal Rocuronium Induced Neuromuscular Blockade Under Sevoflurane Anesthesia Infants</brief_title>
	<detailed_description />
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Rocuronium</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<criteria>Patients age 112 month , ASA physical status 13 underwent elective brain cancer surgery general anesthesia include study young 1month old 12 month . hepatic renal failure A history allergy study medication</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>12 Months</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Sugammadex</keyword>
	<keyword>Rocuronium</keyword>
	<keyword>Infant patient</keyword>
</DOC>